Lastly, the versatility of the pretargeting approach was demonstrated by [18F]TPF capture by a series of cancer-selective bsAbs, targeting clinically relevant cancer-associated cell surface markers MSCP, PD-L1 and EGFR. Here, EGFR is linked to cancer.